Fuzapladib sodium (Synonyms: IS-741 sodium) |
| Catalog No.GC69136 |
Fuzapladib sodium (IS-741 sodium) is an effective orally active inhibitor of phospholipase A2 (phospholipase A2). Fuzapladib sodium can block the adhesion between inflammatory cells and microvascular endothelial cells, inhibit neutrophil infiltration into the pancreas or acute pancreatitis, and has anti-acute pancreatitis effects.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 141284-73-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Fuzapladib sodium
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Fuzapladib sodium
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *